stoxline Quote Chart Rank Option Currency Glossary
  
Stevanato Group S.p.A. (STVN)
21.06  -0.86 (-3.92%)    01-09 16:00
Open: 21.755
High: 21.9998
Volume: 189,365
  
Pre. Close: 21.92
Low: 21
Market Cap: 5,748(M)
Technical analysis
2026-01-09 4:47:33 PM
Short term     
Mid term     
Targets 6-month :  26.2 1-year :  27.89
Resists First :  22.43 Second :  23.87
Pivot price 20.88
Supports First :  20.09 Second :  16.71
MAs MA(5) :  21.47 MA(20) :  20.94
MA(100) :  23.59 MA(250) :  22.92
MACD MACD :  -0.3 Signal :  -0.5
%K %D K(14,3) :  79.6 D(3) :  80.8
RSI RSI(14): 46.5
52-week High :  28 Low :  17.8
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ STVN ] has closed below upper band by 41.4%. Bollinger Bands are 47.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 22.02 - 22.13 22.13 - 22.2
Low: 20.74 - 20.88 20.88 - 20.98
Close: 20.85 - 21.07 21.07 - 21.21
Company Description

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Headline News

Wed, 07 Jan 2026
Sivik Global Healthcare LLC Invests $2.19 Million in Stevanato Group S.p.A. $STVN - MarketBeat

Sat, 03 Jan 2026
Stevanato: Structural Growth Intact, Buy Confirmed (NYSE:STVN) - Seeking Alpha

Fri, 26 Dec 2025
Stevanato Group S.p.A. $STVN Stake Raised by Cooper Investors PTY Ltd. - MarketBeat

Wed, 24 Dec 2025
Are Options Traders Betting on a Big Move in Stevanato Group Stock? - Yahoo Finance

Mon, 22 Dec 2025
Stevanato Group S.p.A. $STVN Stock Holdings Lessened by Riverbridge Partners LLC - MarketBeat

Sun, 21 Dec 2025
Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$20.5 Based On Its Intrinsic Value? - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 50 (M)
Shares Float 49 (M)
Held by Insiders 1.6 (%)
Held by Institutions 110.1 (%)
Shares Short 2,240 (K)
Shares Short P.Month 2,340 (K)
Stock Financials
EPS 0.6
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 6.19
Profit Margin 12 %
Operating Margin 17.7 %
Return on Assets (ttm) 5.3 %
Return on Equity (ttm) 10.1 %
Qtrly Rev. Growth 9.1 %
Gross Profit (p.s.) 6.76
Sales Per Share 23.53
EBITDA (p.s.) 5.34
Qtrly Earnings Growth 18.2 %
Operating Cash Flow 236 (M)
Levered Free Cash Flow -70 (M)
Stock Valuations
PE Ratio 35.09
PEG Ratio 0
Price to Book value 3.4
Price to Sales 0.89
Price to Cash Flow 4.44
Stock Dividends
Dividend 0.05
Forward Dividend 0
Dividend Yield 0.2%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android